Position in SUPN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$73,698,516
+$1,691,069 QoQ
Shares Held
1,425,779
-1.6% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88.6415075548174.ToString("F0")%
Shared 0.ToString("F0")%
None 11.358492445182598.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LOOMIS SAYLES & CO L P holds $194,398,910 across 8 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (37.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
1,425,779 | $73,698,516 | |
| 2 | ALKS |
Alkermes plc.
|
1,784,581 | $63,102,783 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
165,735 | $21,833,928 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
162,986 | $12,533,622 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
375,666 | $12,423,274 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
139,787 | $10,602,843 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
323 | $191,532 | |
| 8 | ZTS |
Zoetis Inc.
|
105 | $12,412 |
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,698,516 | 1,425,779 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $72,007,447 | 1,448,842 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $61,454,928 | 1,285,937 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $40,908,483 | 1,297,858 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $47,181,090 | 1,440,644 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $53,047,696 | 1,467,027 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $47,272,714 | 1,516,123 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $41,627,306 | 1,556,161 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $54,487,893 | 1,597,417 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $47,360,020 | 1,636,490 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $47,703,516 | 1,730,269 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $47,894,748 | 1,593,305 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $56,521,045 | 1,560,062 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,628,612 | 1,559,535 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $54,204,106 | 1,601,303 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $46,589,020 | 1,610,962 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $52,670,610 | 1,629,660 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $48,732,600 | 1,671,214 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $44,020,620 | 1,650,567 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $49,851,011 | 1,619,065 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $11,318,215 | 432,323 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,809,220 | 350,128 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,544,121 | 362,002 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $8,633,172 | 363,502 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,760,120 | 375,771 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||